Results 91 to 100 of about 2,889 (186)

The Risk of Immune‐Mediated Skin Disease Under Dipeptidyl‐Peptidase IV Inhibitor: A Global Population‐Based Study

International Journal of Dermatology, Volume 65, Issue 2, Page 356-358, February 2026.
Noor Mruwat, Noga Givon‐Lavi, Ralf J. Ludwig, Khalaf Kridin   +3 more
wiley   +1 more source

Pyostomatitis vegetans : a review of the literature [PDF]

, 2009
Pyostomatitis vegetans (PV) is a rare condition characterized by pustules that affect the oral mucosa. It is a highly specific marker for inflammatory bowel disease and its correct recognition may lead to the diagnosis of ulcerative colitis or Crohn?s ...
Buonaiuto, Curzio, Cirillo, Nicola, Dell?Ermo, Antonio, Femiano, Felice, Lanza, Alessandro, Perillo, Letizia   +5 more
core  

Epidermolysis bullosa acquisita with moderately severe dysphagia due to esophageal strictures

Indian Journal of Dermatology, 2011
Epidermolysis bullosa acquisita (EBA) is a chronic, autoimmune condition involving the skin and mucous membranes. Symptomatic mucosal involvement is rare, but can impact on quality of life, due to esophageal strictures and dysphagia.
Jenny Tu, Prasad W Kumarasinghe
doaj   +1 more source

Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic non-inferiority randomised controlled trial [PDF]

, 2017
Background: Bullous pemphigoid (BP) is a blistering skin disorder with increased mortality. We tested whether a strategy of starting treatment with doxycycline conveys acceptable short-term blister control whilst conferring long-term safety advantages ...
A Anstey, A Carmichael, A Lloyd Lavery, A M Layton, A Omerod, Adam Ferguson, Adzura Azam, Alex Waters, Andrew Ilchyshyn, Andrew J Nunn, Andrew Wright, Anna Chapman, B Walker, Bastuji-Garin, Bratton, Brick, C Barnard, C Günthert, C Thomas, Chalmers, Chalmers, Chris Bower, Chris Lovell, D'Agostino, David Gawkrodger, Diane Whitham, E Bröcker, E Veysey, Emilia Duarte-Williamson, Enno Schmidt, F Craig, Feliciani, Fenella Wojnarowska, Fiona Antony, Fivenson, G Patel, G Wong, Goon, Gudula Kirtschig, H Bell, H Malhomme, H Santander, Hofmann, Hywel C Williams, Indre Verpetinske, Ingrid Salvary, J Adams, J English, J Ingram, J Ravenscroft, J Wee, James Mason, Jane Sterling, Joanne R Chalmers, Joly, Joly, Joly, K Davies, K Hussain, K Steinbrink, Karen Gibbon, Karen Harman, Kathy Taghipour, Kirtschig, Langan, Lever, Lloyd-Lavery, M G S Dunnill, M Sticherling, M Vatve, M Walsh, M Westmoreland, Margaret Childs, Marinella Nik, Meijer, Monk, Murrell, N Hepburn, N J Levell, N van Beek, Offen, P J Hampton, R Ellis, R Gläser, R Groves, R Hügel, R R Coelho, R Rallan, R Wachsmuth, Riond, Robert Charles-Holmes, Roujeau, S Blackford, S Wahie, Sam Gibbs, Savin, Schmidt, Schulze, Shernaz Walton, Sobocinski, Taghipour, Taghipour, Thomas Luger, Thomas R Godec, V Akhras, V Lewis, V Venning, Venning, Walter Bottomley   +108 more
core   +4 more sources

A case report of the use of rituximab and the Epidermolysis Bullosa Disease Activity Scoring Index (EBDASI) in a patient with epidermolysis bullosa acquisita with extensive esophageal involvement [PDF]

, 2018
A 49-year-old man with recalcitrant mechanobullous epidermolysis bullosa acquisita (EBA) with significant esophageal involvement was treated with rituximab. EBA is a chronic autoimmune subepidermal bullous disease.
Anes Yang, Dedee Murrell, Minhee Kim, Philip Craig   +3 more
core   +1 more source

Effectiveness and side effects of anti-CD20 therapy for autoantibody-mediated blistering skin diseases: A comprehensive survey of 71 consecutive patients from the Initial use to 2007

Therapeutics and Clinical Risk Management, 2008
Jennifer D Peterson1, Lawrence S Chan2,3,41Department of Dermatology, Texas Tech University Health Sciences Center at Lubbock, Lubbock, TX, USA; 2Department of Dermatology; 3Department of Microbiology/Immunology, University of Illinois at Chicago ...
Jennifer D Peterson, Lawrence S Chan
doaj  

Ocular manifestations and management of autoimmune bullous diseases

Journal of Ophthalmic & Vision Research, 2019
Autoimmune bullous diseases with ocular involvement consist of a group of systemic entities that are characterized by formation of autoantibodies against the proteins of the epithelial basement membrane zone of the conjunctiva.
Sepehr Feizi, Danial Roshandel
doaj   +1 more source

Epidermolysis Bullosa Acquisita-Current and Emerging Treatments. [PDF]

J Clin Med, 2023
Tešanović Perković D, Bukvić Mokos Z, Marinović B.   +2 more
europepmc   +1 more source

Acquired epidermolysis bullosa

Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta, 2015
Epidermolysis bullosa is a group of diseases or skin disorders genetically transmitted and it is characterized by the appearance of bullae, ulcers and skin wounds. It usually appears at birth or in the first months of life.
Maricel Sucar Batista, Yanier Serrano García, Taimí Miranda Vergara   +2 more
doaj  

Erythrodermic Epidermolysis Bullosa Acquisita [PDF]

JAMA Dermatology, 2015
Häfliger, Stefanie, Klötgen, Hans-Wilhelm, Horn, Michael Peter, Beltraminelli, Helmut, Borradori, Luca   +4 more
openaire   +3 more sources